Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
about
Targeting survivin in cancer therapySurvivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR.Survivin study: an update of "what is the next wave"?Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.Novel miRNA-mRNA interactions conserved in essential cancer pathways.Clinico-pathologic relevance of Survivin splice variant expression in cancerProtein Sam68 regulates the alternative splicing of survivin DEx3.Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS.High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.Diagnostic relevance of autoantibody detection against inhibitors of apoptosis proteins in colon cancer and colon adenomaThe clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers.Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell.Targeting survivin as a potential new treatment for chondrosarcoma of bone.HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer.High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients.Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2/neu, and survivin.
P2860
Q28273083-085DB6FF-8C9F-4377-9620-8670649D447DQ34757482-A85FA9F8-D7C5-4CAC-A057-885C5CFF0F62Q36430244-70BDB19E-F700-4A51-BECC-615A87D08B68Q36609488-DA6F9AB2-1636-4272-A3E4-734972C0D343Q37741366-3DF9F770-254C-4F2A-AE4D-00F0A27ABAF1Q38116267-9537D017-1FE3-4E83-9554-CEF180CD88ABQ38698809-A239D840-E66C-48D6-9CDC-969D83BB96C7Q38853955-DA819486-A84D-45D2-B295-2B98D0DE0B54Q41026125-28238331-4711-45D8-94CC-7C1275803650Q41766299-3EC90597-005B-4AAC-B884-725163CEE178Q41772107-D31989FF-D1F3-4F15-83E1-CE3581F59B50Q42212985-409978AE-FF0B-41B2-9522-34E7BF1E2A4BQ42419178-98F457F4-DDA2-4968-8D4D-8B3C6D7CD477Q43166550-B90C62CB-2413-4F4F-BF35-BB13FC42F722Q45930927-9FE5A37A-20E4-4795-B508-FC94ED8F538FQ54540314-1C2CADB3-ED20-41D9-98E8-76FBBBAFE9F1
P2860
Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Elevated expression of survivi ...... soft-tissue sarcomas patients.
@ast
Elevated expression of survivi ...... soft-tissue sarcomas patients.
@en
type
label
Elevated expression of survivi ...... soft-tissue sarcomas patients.
@ast
Elevated expression of survivi ...... soft-tissue sarcomas patients.
@en
prefLabel
Elevated expression of survivi ...... soft-tissue sarcomas patients.
@ast
Elevated expression of survivi ...... soft-tissue sarcomas patients.
@en
P2093
P2860
P356
P1433
P1476
Elevated expression of survivi ...... soft-tissue sarcomas patients.
@en
P2093
Christine Lautenschläger
Frank Bartel
Hannelore Schmidt
Karen Blümke
Matthias Bache
Matthias Kappler
Peter Würl
Steffen Hauptmann
Thomas Köhler
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208702
P407
P577
2005-08-01T00:00:00Z
P5875
P6179
1005337030